产品名称 | NebuSelect™ Recombinant Biotinylated Human CD30/TNFRSF8, Avi-His-tag |
---|---|
目录号 | NBL-242917 |
别名 | CD30/TNFRSF8; CD30; CD30KI-1; CD30L receptor; TNFRSF8; D1S166EKi-1; CD30KI-1 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P28908-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242917-100ug | 100ug | Inquire | Inquire | |
NBL-242917-1mg | 1mg | Inquire | Inquire | |
NBL-242917-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human CD30/TNFRSF8, Avi-His-tag
Catalog#:
NBL-242917
Description:
NebuSelect™ Recombinant Biotinylated Human CD30/TNFRSF8, Avi-His-tag(Cat#NBL-242917) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Phe19-Lys379.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 41.3 kDa. Due to glycosylation, the protein migrates to 70-100 kDa based on Bis-Tris PAGE result.
Target Name:
CD30/TNFRSF8; CD30; CD30KI-1; CD30L receptor; TNFRSF8; D1S166EKi-1; CD30KI-1
Target Information:
The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in subpopulations of activated T-and B-cells in nonpathologic conditions. CD30 expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs).
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.